Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2003
09/04/2003CA2477225A1 Novel compositions and methods for cancer
09/04/2003CA2477037A1 Recombinant negative strand virus rna expression systems and vaccines
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003CA2476776A1 Reagents and treatment methods for autoimmune diseases
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/04/2003CA2476480A1 Methods of making hypermutable cells using pmsr homologs
09/04/2003CA2475526A1 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
09/04/2003CA2475509A1 Treatment methods using anti-cd22 antibodies
09/04/2003CA2474805A1 Combinations of (a) an atp-competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents
09/04/2003CA2459155A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/04/2003CA2451982A1 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
09/03/2003EP1340979A2 Neuropeptide receptor and uses thereof
09/03/2003EP1340818A1 Method and nucleic acids for the analysis of a colon cell proliferative disorder
09/03/2003EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity
09/03/2003EP1340759A1 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340745A1 Indirubin derivatives and their use for the treatment of cancer
09/03/2003EP1340505A2 Therapeutic use of cis-element decoys in vivo
09/03/2003EP1340498A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/03/2003EP1339871A1 Diagnosis and treatment of tumor-suppressor associated disorders
09/03/2003EP1339862A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol
09/03/2003EP1339854A2 Lipid metabolism enzymes
09/03/2003EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof
09/03/2003EP1339846A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339844A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339834A2 Enzymes
09/03/2003EP1339753A2 Percarboxylated polysaccharides, and a process for their preparation
09/03/2003EP1339748A2 G-protein coupled receptors
09/03/2003EP1339736A2 Oncolytic virus
09/03/2003EP1339735A1 Method for preparing tryptophan rich peptides
09/03/2003EP1339721A2 Hydroxyesters of 7-desmethylrapamycin
09/03/2003EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof
09/03/2003EP1339715A2 Heterocyclic ether substituted imidazoquinolines
09/03/2003EP1339713A2 Saframycins, analogues and uses thereof
09/03/2003EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists
09/03/2003EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
09/03/2003EP1339708A2 Indole-type inhibitors of p38 kinase
09/03/2003EP1339703A1 A process for the preparation of paclitaxel
09/03/2003EP1339702A1 5-amide substituted diarylamines as mek inhibitors
09/03/2003EP1339698A2 Pyrimidine derivatives
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/03/2003EP1339695A1 Farnesyltransferase inhibitors
09/03/2003EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
09/03/2003EP1339686A2 Cyanoguanidine prodrugs
09/03/2003EP1339683A2 Estrogen receptor modulators
09/03/2003EP1339680A1 Substituted oxindole derivatives as tyrosine kinase inhibitors
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339665A1 Nitroderivatives as drugs for diseases having an inflammatory basis
09/03/2003EP1339662A1 Novel estrogen receptor ligands and methods iii
09/03/2003EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
09/03/2003EP1339433A2 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma
09/03/2003EP1339425A2 Vaccine composition containing transforming growth factor alpha
09/03/2003EP1339420A1 Process for preparing aqueous extracts of plants and extracts so obtained
09/03/2003EP1339415A1 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
09/03/2003EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines
09/03/2003EP1339405A1 Use of anti-muscarinic agents and calcium channel blockers in combination
09/03/2003EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
09/03/2003EP1339399A2 Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
09/03/2003EP1214300B1 Rate-controlled particles
09/03/2003EP1140048B1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases
09/03/2003EP1095038B1 Antagonists of gonadotropin releasing hormone
09/03/2003EP1090014B1 Arylsulfonanilide phosphates
09/03/2003EP1070065B1 Azabicyclic 5ht1 receptor ligands
09/03/2003EP0993454B1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
09/03/2003EP0984936B1 Cyanoguanidines as cell proliferation inhibitors
09/03/2003EP0977733B1 Arylsulfonylamino hydroxamic acid derivatives
09/03/2003EP0876359B1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
09/03/2003EP0857210B1 Therapeutic antiangiogenic compositions and methods
09/03/2003EP0775156B1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives
09/03/2003EP0651646B1 Therapeutic conjugates of toxins and drugs
09/03/2003CN1440462A Method of identifying and producing antigen peptides and use thereof as vaccines
09/03/2003CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
09/03/2003CN1440414A Synthesis of cuttlefish compound
09/03/2003CN1440412A Thienopyrrolidinones
09/03/2003CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use
09/03/2003CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
09/03/2003CN1440403A Quinazoline ditosylate salt compounds
09/03/2003CN1440402A N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/03/2003CN1440395A COLCHINOL derivatives as vascular damaging agents
09/03/2003CN1440391A Propane-1,3-dione derivatives
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1440292A Pyrido[2,3-D] rimidine and pyrimido[4,5-D] pyrimidine nucleosides
09/03/2003CN1440278A Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethy lene) cytidine
09/03/2003CN1439641A Anti-cancer chemicals of methotrexate derivatives and their uses in pharmaceutical science
09/03/2003CN1439426A Medicine composition and preparation and use thereof
09/03/2003CN1439425A Anticancer medicine made from phytohemagglutinin
09/03/2003CN1439418A Auxiliary medicine for cancer and preparation thereof
09/03/2003CN1439381A Separating method, medicinal use and preparation of medicinal components of anaerobic corynebacterium parvum
09/03/2003CN1439366A Stable heptyl platinum solution preparation
09/03/2003CN1439312A Anticancer beverage and preparation thereof
09/03/2003CN1120173C Antitumor substance extracted from Grifola
09/03/2003CN1120166C New class of benzoporphyrin derivative photoactive compounds
09/03/2003CN1120161C Partially synthetic taxinane with antineoplastic activity
09/03/2003CN1120160C Isoxazole and cortonamide derivatives and their use as pharmaceuticals and disgnositics
09/03/2003CN1120007C Medicine for treating mastopathy
09/03/2003CN1120002C Application of ammonium nilrate in pharmaceutical industry, food and health-care product
09/03/2003CN1119994C Oral preparation for prophylactic and therapeutic treatment of helicobacter sp. infection
09/02/2003US6613942 Glucagon antagonists/inverse agonists
1 ... 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 ... 2211